Our locations are open for all appointments and procedures, including COVID-19 testing. Schedule an appointment online or call your doctor’s office. Patients may now be accompanied by visitors. Read our updated visitor policy.

Skip to main content
NYU Langone Provider

Jose Alberto Palma Carazo, MD, PhD

NYU Langone Provider
  • Specialties: Autonomic Disorders, Neurology
  • Languages: English, Spanish
  • Phone: 212-263-7225
View Locations

Conditions and Treatments

  • multiple system atrophy
  • Parkinson's disease
  • orthostatic hypotension
  • autonomic neuropathy
  • dysautonomia
  • fainting
  • familial dysautonomia
  • autonomic failure

Education and Training
  • Fellowship, NYU School of Medicine, Neurology, 2015
  • PhD from University Of Navarra, 2013
  • Residency, Universidad de Navarra Facultad de Medicina, Neurology, 2012
  • MD from University Of Navarra, 2007

Is this your profile?

Edit profile

This provider accepts the following insurance plans.

  • Medicare
This list of insurances changes regularly, and insurance plans listed may not be accepted at all office locations for this provider. Before your appointment, please confirm with your insurance company that this provider accepts your insurance.

Locations and Appointments

Dysautonomia Center

530 First Avenue, Suite 9Q
New York, NY 10016


clinical trials, multiple system atrophy, autonomic failure, orthostatic hypotension, hereditary sensory and autonomic neuropathy, familial dysautonomia, autonomic autoimmune ganglionopathy, autonomic disorders

Research Summary

Dr. Palma's work over the past years has focused on the description of the autonomic phenotype and the search for biomarkers in patients with neurodegenerative autonomic disorders, including multiple system atrophy (MSA), Parkinson disease (PD) and pure autonomic failure (PAF).

Dr. Palma is one of the international coordinators of the Natural History Study of the Synucleinopathies. He is the principal or co-investigator in clinical trials for neurogenic orthostatic hypotension and multiple system atrophy as well as in the development of biomarkers of disease diagnosis and progression.

His work in rare diseases is also focused on genetic autonomic disorders. Dr. Palma is interested in defining the phenotype and genotype of and clinical trial design and conduct for familial dysautonomia (Riley-Day syndrome) and other rare hereditary sensory autonomic neuropathies (HSAN).

Academic Contact

Academic office

530 First Avenue

Ninth Floor

New York, NY 10016

These focus areas and their associated publications are derived from PubMed and the MeSH term library. *
represents one publication
*Due to PubMed processing times, the most recent publications may not be reflected in the timeline.

  • A Randomized Double-Blind Placebo-Controlled Parallel-Group Study to Evaluate the Efficacy and Safety of BHV-3241 in Subjects with Multiple System Atrophy (MSA)

    Learn More
  • A Phase 3 22-week Multi-center Randomized Withdrawal Study of TD-9855 in Treating Symptomatic Neurogenic Orthostatic Hypotension in Subjects with Primary Autonomic Failure

    Learn More
  • A Phase 3 4-week Multicenter Randomized Double-blind Placebo-controlled Parallel-group Study of TD-9855 in Treating Symptomatic Neurogenic Orthostatic Hypotension in Subjects With Primary Autonomic Failure

    Learn More
View All Research Studies (6)

Read All Publications (69)

Related News